Insulin-like growth factor binding protein-3: A novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3316-3319

  Shaarawy, Mohamed ^a,c   Fikry, Mohamed Amin ^b   Massoud, Baher Aly ^b   Lotfy, Samar ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Roxy Building ^*  (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNORADIOMETRIC ASSAY; LIVER CELL; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 7844239325     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.9.5082     Document Type: Article

References (16)

1. Hossenlopp P, Seurin D, Segovia B, Protolan G, Binoux M. 1987 Heterogenity of insulin-like growth factor binding proteins and relationship between structure and affinity. Eur J Biochem. 170:133-142.
2. Baxter RC, Martin JL. 1986 Radioimmunoassay of growth hormone dependent insulin-like growth factor binding proteins in human plasma. J Clin Invest. 78:1504-1512.
3. Baxter RC. 1986 The somatomedins: insulin-like growth factors. Adv Clin Biochem. 25:49-115.
4. Bar RS, Harrison LC, Baxter RC, et al. 1987 Production of IGF-binding proteins by vascular endothelial cells. Biochem Biophys Res Commun. 148:734-739.
5. Blum WF, Alberton-Wikland K, Rosberg S, Ranke MB. 1993 Serum levels of insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab. 76:1610-1616.
6. Kanety H, Karasik A, Klinger B, Silbergeld A, Laron Z. 1993 Long treatment of Laron type dwarfs with IGF-1 increases IGFBP-3 in the absence of growth hormone activity. Acta Endocrinol (Copenh). 128:144-149.
7. Zapf J, Kiefer M, Merryweather JU, et al. 1990 Isolation from adult human serum of four IGFBPs and molecular cloning of one of them. J Biol Chem. 265:14892-14898.
8. Hintz RL. 1981 Plasma forms of somatomedin and the binding protein phenomenon. Clin Endocrinol Metab. 13:31-42.
9. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. 1995 GH, IGF-1 and IGFBP-3 in chronic liver disease. Hepatology. 21:680-688.
10. Guink P, Owens P, Moyse K, et al. 1994 IGF-1 and IGF-2 are reduced in plasma from growth retarded children with chronic liver disease. Growth Regul. 4:35-38.
11. Galen RS, Gambino SR. 1975 Beyond normality. The predictive value and efficiency of medical diagnosis. New York: John Willey & Sons; p. 124.
12. Tavil AS. 1972 The synthesis and degradation of liver produced proteins. Gut 13:225-235.
13. Sherlock S. 1993 Assessment of liver function. In: Sherlock S, Dooley J, eds. Diseases of the liver and biliarly system. London: Blackwell Scientific; p. 17.
14. Underwood LE, Smith EP, Glommons DR. 1988 The production and actions of IGFs, their relationship to nutrition and growth. In: Tanner JM, ed. Oxford: Smith Gordon; p 235-249.
15. Martin JL, Willetts KE, Baxter RC. 1990 Cloning and characterization of GH dependent IGFBP-3 in the rat. J Biol Chem. 265:4214-4230.
16. Scott CD, Martin IL, Baxter RC. 1985 Production of IGF-1 and its binding protein by adult rat hepatocytes in primary culture. Endocrinology. 116:1094-1101.